{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:41:55Z","timestamp":1781721715729,"version":"3.54.5"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01 NS083164"],"award-info":[{"award-number":["R01 NS083164"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer&apos;s Drug Discovery Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer&apos;s Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eastern Chapter of the North Carolina Alzheimer&amp;#x2019;s Association"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Age-related degeneration of basal forebrain cholinergic neurons (BFCNs) is linked to cognitive impairment. The p75 neurotrophin receptor (p75<jats:sup>NTR<\/jats:sup>) has been proposed to mediate neuronal degeneration in aging. Therefore, we tested the hypothesis that modifying p75<jats:sup>NTR<\/jats:sup> function would prevent or reverse aging-related neuronal degeneration using LM11A-31, a small molecule p75<jats:sup>NTR<\/jats:sup> modulator that downregulates degenerative and upregulates trophic receptor-associated signaling. Morphological analysis in mice showed loss of BFCN area detectable by 18 months of age. Oral administration of LM11A-31 from age 15 to 18 months resulted in a dose-related preservation of BFCN area and one month of treatment from 17 to 18 months also preserved cell area. To evaluate reversal of established neuronal atrophy, animals were treated from 21 to 25 months of age. Treatment was associated with an increase of cell size to a mean area larger than that observed at 18 months, accompanied by increases in mean MS\/VDB neurite length, as well as increased cholinergic fiber density and synaptophysin pre-synaptic marker levels in the hippocampus. These findings support the idea that modulation of p75<jats:sup>NTR<\/jats:sup> activity can prevent and potentially reverse age-associated BFCN degeneration. Moreover, this may be achieved therapeutically with orally bioavailable agents such as LM11A-31.<\/jats:p>","DOI":"10.1038\/s41598-019-41654-8","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T16:49:55Z","timestamp":1553705395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Modulation of the p75 neurotrophin receptor suppresses age-related basal forebrain cholinergic neuron degeneration"],"prefix":"10.1038","volume":"9","author":[{"given":"Youmei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick B.","family":"Meeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"41654_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/hipo.1108","volume":"12","author":"N Aznavour","year":"2002","unstructured":"Aznavour, N., Mechawar, N. & Descarries, L. Comparative analysis of cholinergic innervation in the dorsal hippocampus of adult mouse and rat: a quantitative immunocytochemical study. Hippocampus 12, 206\u2013217, https:\/\/doi.org\/10.1002\/hipo.1108 (2002).","journal-title":"Hippocampus"},{"key":"41654_CR2","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0079-6123(03)45004-8","volume":"145","author":"MM Mesulam","year":"2004","unstructured":"Mesulam, M. M. The cholinergic innervation of the human cerebral cortex. Prog Brain Res 145, 67\u201378, https:\/\/doi.org\/10.1016\/S0079-6123(03)45004-8 (2004).","journal-title":"Prog Brain Res"},{"key":"41654_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuron.2011.04.026","volume":"71","author":"Z Gu","year":"2011","unstructured":"Gu, Z. & Yakel, J. L. Timing-dependent septal cholinergic induction of dynamic hippocampal synaptic plasticity. Neuron 71, 155\u2013165, https:\/\/doi.org\/10.1016\/j.neuron.2011.04.026 (2011).","journal-title":"Neuron"},{"key":"41654_CR4","doi-asserted-by":"publisher","first-page":"9297","DOI":"10.1523\/JNEUROSCI.23-28-09297.2003","volume":"23","author":"LS Leung","year":"2003","unstructured":"Leung, L. S., Shen, B., Rajakumar, N. & Ma, J. Cholinergic activity enhances hippocampal long-term potentiation in CA1 during walking in rats. J Neurosci 23, 9297\u20139304 (2003).","journal-title":"J Neurosci"},{"key":"41654_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.brainres.2009.10.048","volume":"1308","author":"S Duzel","year":"2010","unstructured":"Duzel, S. et al. Basal forebrain integrity and cognitive memory profile in healthy aging. Brain Res 1308, 124\u2013136, https:\/\/doi.org\/10.1016\/j.brainres.2009.10.048 (2010).","journal-title":"Brain Res"},{"key":"41654_CR6","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cercor\/bhv349","volume":"27","author":"MA Al-Onaizi","year":"2017","unstructured":"Al-Onaizi, M. A. et al. Regulation of Cognitive Processing by Hippocampal Cholinergic Tone. Cereb Cortex 27, 1615\u20131628, https:\/\/doi.org\/10.1093\/cercor\/bhv349 (2017).","journal-title":"Cereb Cortex"},{"key":"41654_CR7","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus, R. T., Dean, R. L. 3rd, Beer, B. & Lippa, A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408\u2013414 (1982).","journal-title":"Science"},{"key":"41654_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0959-4388(95)80022-0","volume":"5","author":"M Gallagher","year":"1995","unstructured":"Gallagher, M. & Colombo, P. J. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 5, 161\u2013168 (1995).","journal-title":"Curr Opin Neurobiol"},{"key":"41654_CR9","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.neurobiolaging.2007.04.001","volume":"29","author":"AR Ypsilanti","year":"2008","unstructured":"Ypsilanti, A. R., da Cruz, G., Burgess, M. T. & Aubert, A. I. The length of hippocampal cholinergic fibers is reduced in the aging brain. Neurobiol Aging 29, 1666\u20131679, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.04.001 (2008).","journal-title":"Neurobiol Aging"},{"key":"41654_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bbr.2010.11.058","volume":"221","author":"R Schliebs","year":"2011","unstructured":"Schliebs, R. & Arendt, T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res 221, 555\u2013563, https:\/\/doi.org\/10.1016\/j.bbr.2010.11.058 (2011).","journal-title":"Behav Brain Res"},{"key":"41654_CR11","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","volume":"34","author":"M Grothe","year":"2013","unstructured":"Grothe, M., Heinsen, H. & Teipel, S. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer\u2019s disease. Neurobiol Aging 34, 1210\u20131220, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.10.018 (2013).","journal-title":"Neurobiol Aging"},{"key":"41654_CR12","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.biopsych.2011.06.019","volume":"71","author":"M Grothe","year":"2012","unstructured":"Grothe, M., Heinsen, H. & Teipel, S. J. Atrophy of the cholinergic Basal forebrain over the adult age range and in early stages of Alzheimer\u2019s disease. Biol Psychiatry 71, 805\u2013813, https:\/\/doi.org\/10.1016\/j.biopsych.2011.06.019 (2012).","journal-title":"Biol Psychiatry"},{"key":"41654_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuropsychologia.2013.11.002","volume":"53","author":"D Wolf","year":"2014","unstructured":"Wolf, D. et al. Association of basal forebrain volumes and cognition in normal aging. Neuropsychologia 53, 54\u201363, https:\/\/doi.org\/10.1016\/j.neuropsychologia.2013.11.002 (2014).","journal-title":"Neuropsychologia"},{"key":"41654_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini, L. et al. Brain atrophy in Alzheimer\u2019s Disease and aging. Ageing Res Rev 30, 25\u201348, https:\/\/doi.org\/10.1016\/j.arr.2016.01.002 (2016).","journal-title":"Ageing Res Rev"},{"key":"41654_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0197-4580(02)00057-X","volume":"24","author":"SA Lyness","year":"2003","unstructured":"Lyness, S. A., Zarow, C. & Chui, H. C. Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24, 1\u201323 (2003).","journal-title":"Neurobiol Aging"},{"key":"41654_CR16","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/1073858408331376","volume":"15","author":"EJ Coulson","year":"2009","unstructured":"Coulson, E. J., May, L. M., Sykes, A. M. & Hamlin, A. S. The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer\u2019s disease. Neuroscientist 15, 317\u2013323, https:\/\/doi.org\/10.1177\/1073858408331376 (2009).","journal-title":"Neuroscientist"},{"key":"41654_CR17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1093\/cercor\/bhp232","volume":"20","author":"M Grothe","year":"2010","unstructured":"Grothe, M. et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer\u2019s disease. Cereb Cortex 20, 1685\u20131695, https:\/\/doi.org\/10.1093\/cercor\/bhp232 (2010).","journal-title":"Cereb Cortex"},{"key":"41654_CR18","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.ajpath.2011.07.044","volume":"179","author":"L Vana","year":"2011","unstructured":"Vana, L. et al. Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer\u2019s disease. Am J Pathol 179, 2533\u20132550, https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.044 (2011).","journal-title":"Am J Pathol"},{"key":"41654_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1136\/jnnp.2010.217133","volume":"82","author":"H Zhang","year":"2011","unstructured":"Zhang, H. et al. Grey matter atrophy of basal forebrain and hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry 82, 487\u2013493, https:\/\/doi.org\/10.1136\/jnnp.2010.217133 (2011).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"41654_CR20","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1002\/cne.23415","volume":"521","author":"MM Mesulam","year":"2013","unstructured":"Mesulam, M. M. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease. J Comp Neurol 521, 4124\u20134144, https:\/\/doi.org\/10.1002\/cne.23415 (2013).","journal-title":"J Comp Neurol"},{"key":"41654_CR21","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neurobiolaging.2016.02.031","volume":"42","author":"CT Tiernan","year":"2016","unstructured":"Tiernan, C. T. et al. Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer\u2019s disease. Neurobiol Aging 42, 80\u201390, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.02.031 (2016).","journal-title":"Neurobiol Aging"},{"key":"41654_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.brainres.2017.06.023","volume":"1670","author":"G Pepeu","year":"2017","unstructured":"Pepeu, G. & Grazia Giovannini, M. The fate of the brain cholinergic neurons in neurodegenerative diseases. Brain Res 1670, 173\u2013184, https:\/\/doi.org\/10.1016\/j.brainres.2017.06.023 (2017).","journal-title":"Brain Res"},{"key":"41654_CR23","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jnr.490410308","volume":"41","author":"IM Parhad","year":"1995","unstructured":"Parhad, I. M. et al. Axonal atrophy in aging is associated with a decline in neurofilament gene expression. J Neurosci Res 41, 355\u2013366, https:\/\/doi.org\/10.1002\/jnr.490410308 (1995).","journal-title":"J Neurosci Res"},{"key":"41654_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0031-9384(03)00219-1","volume":"80","author":"LM Veng","year":"2003","unstructured":"Veng, L. M., Granholm, A. C. & Rose, G. M. Age-related sex differences in spatial learning and basal forebrain cholinergic neurons in F344 rats. Physiol Behav 80, 27\u201336 (2003).","journal-title":"Physiol Behav"},{"key":"41654_CR25","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/NEN.0b013e31816a1df3","volume":"67","author":"C Geula","year":"2008","unstructured":"Geula, C., Nagykery, N., Nicholas, A. & Wu, C. K. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 67, 309\u2013318, https:\/\/doi.org\/10.1097\/NEN.0b013e31816a1df3 (2008).","journal-title":"J Neuropathol Exp Neurol"},{"key":"41654_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0197-4580(00)00087-7","volume":"21","author":"NL Ward","year":"2000","unstructured":"Ward, N. L., Stanford, L. E., Brown, R. E. & Hagg, T. Cholinergic medial septum neurons do not degenerate in aged 129\/Sv control or p75(NGFR)\u2212\/\u2212mice. Neurobiol Aging 21, 125\u2013134 (2000).","journal-title":"Neurobiol Aging"},{"key":"41654_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00429-014-0737-5","volume":"220","author":"M Dokter","year":"2015","unstructured":"Dokter, M. et al. Implications of p75NTR for dentate gyrus morphology and hippocampus-related behavior revisited. Brain Struct Funct 220, 1449\u20131462, https:\/\/doi.org\/10.1007\/s00429-014-0737-5 (2015).","journal-title":"Brain Struct Funct"},{"key":"41654_CR28","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0306-4522(00)00260-8","volume":"100","author":"U Greferath","year":"2000","unstructured":"Greferath, U., Bennie, A., Kourakis, A. & Barrett, G. L. Impaired spatial learning in aged rats is associated with loss of p75-positive neurons in the basal forebrain. Neuroscience 100, 363\u2013373 (2000).","journal-title":"Neuroscience"},{"key":"41654_CR29","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1523\/JNEUROSCI.2364-14.2014","volume":"34","author":"Z Boskovic","year":"2014","unstructured":"Boskovic, Z. et al. The role of p75NTR in cholinergic basal forebrain structure and function. J Neurosci 34, 13033\u201313038, https:\/\/doi.org\/10.1523\/JNEUROSCI.2364-14.2014 (2014).","journal-title":"J Neurosci"},{"key":"41654_CR30","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.neurobiolaging.2013.12.017","volume":"35","author":"D Riascos","year":"2014","unstructured":"Riascos, D. et al. Alterations of Ca(2)(+)-responsive proteins within cholinergic neurons in aging and Alzheimer\u2019s disease. Neurobiol Aging 35, 1325\u20131333, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.12.017 (2014).","journal-title":"Neurobiol Aging"},{"key":"41654_CR31","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.20100","volume":"55","author":"M Mesulam","year":"2004","unstructured":"Mesulam, M., Shaw, P., Mash, D. & Weintraub, S. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55, 815\u2013828, https:\/\/doi.org\/10.1002\/ana.20100 (2004).","journal-title":"Ann Neurol"},{"key":"41654_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrn1809","volume":"7","author":"SN Burke","year":"2006","unstructured":"Burke, S. N. & Barnes, C. A. Neural plasticity in the ageing brain. Nat Rev Neurosci 7, 30\u201340, https:\/\/doi.org\/10.1038\/nrn1809 (2006).","journal-title":"Nat Rev Neurosci"},{"key":"41654_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.phrs.2017.04.024","volume":"121","author":"J Meldolesi","year":"2017","unstructured":"Meldolesi, J. Neurotrophin receptors in the pathogenesis, diagnosis and therapy of neurodegenerative diseases. Pharmacol Res 121, 129\u2013137, https:\/\/doi.org\/10.1016\/j.phrs.2017.04.024 (2017).","journal-title":"Pharmacol Res"},{"key":"41654_CR34","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1007\/s12035-017-0505-7","volume":"55","author":"RO Costa","year":"2018","unstructured":"Costa, R. O., Perestrelo, T. & Almeida, R. D. PROneurotrophins and CONSequences. Mol Neurobiol 55, 2934\u20132951, https:\/\/doi.org\/10.1007\/s12035-017-0505-7 (2018).","journal-title":"Mol Neurobiol"},{"key":"41654_CR35","doi-asserted-by":"publisher","first-page":"460543","DOI":"10.4061\/2011\/460543","volume":"2011","author":"AM Fortress","year":"2011","unstructured":"Fortress, A. M., Buhusi, M., Helke, K. L. & Granholm, A. C. Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats. J Aging Res 2011, 460543, https:\/\/doi.org\/10.4061\/2011\/460543 (2011).","journal-title":"J Aging Res"},{"key":"41654_CR36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nature02319","volume":"427","author":"A Nykjaer","year":"2004","unstructured":"Nykjaer, A. et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843\u2013848, https:\/\/doi.org\/10.1038\/nature02319 (2004).","journal-title":"Nature"},{"key":"41654_CR37","doi-asserted-by":"publisher","unstructured":"Ioannou, M. S. & Fahnestock, M. ProNGF, but Not NGF, Switches from Neurotrophic to Apoptotic Activity in Response to Reductions in TrkA Receptor Levels. Int J Mol Sci 18, https:\/\/doi.org\/10.3390\/ijms18030599 (2017).","DOI":"10.3390\/ijms18030599"},{"key":"41654_CR38","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1111\/j.1460-9568.2008.06152.x","volume":"27","author":"R Al-Shawi","year":"2008","unstructured":"Al-Shawi, R. et al. Neurotoxic and neurotrophic roles of proNGF and the receptor sortilin in the adult and ageing nervous system. Eur J Neurosci 27, 2103\u20132114, https:\/\/doi.org\/10.1111\/j.1460-9568.2008.06152.x (2008).","journal-title":"Eur J Neurosci"},{"key":"41654_CR39","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.physbeh.2010.11.005","volume":"102","author":"AV Terry Jr.","year":"2011","unstructured":"Terry, A. V. Jr., Kutiyanawalla, A. & Pillai, A. Age-dependent alterations in nerve growth factor (NGF)-related proteins, sortilin, and learning and memory in rats. Physiol Behav 102, 149\u2013157, https:\/\/doi.org\/10.1016\/j.physbeh.2010.11.005 (2011).","journal-title":"Physiol Behav"},{"key":"41654_CR40","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1523\/JNEUROSCI.17-20-07594.1997","volume":"17","author":"TT Yeo","year":"1997","unstructured":"Yeo, T. T. et al. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci 17, 7594\u20137605 (1997).","journal-title":"J Neurosci"},{"key":"41654_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1046\/j.1460-9568.2000.00976.x","volume":"12","author":"U Greferath","year":"2000","unstructured":"Greferath, U. et al. Enlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice. Eur J Neurosci 12, 885\u2013893 (2000).","journal-title":"Eur J Neurosci"},{"key":"41654_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jnr.22735","volume":"90","author":"U Greferath","year":"2012","unstructured":"Greferath, U., Trieu, J. & Barrett, G. L. The p75 neurotrophin receptor has nonapoptotic antineurotrophic actions in the basal forebrain. J Neurosci Res 90, 278\u2013287, https:\/\/doi.org\/10.1002\/jnr.22735 (2012).","journal-title":"J Neurosci Res"},{"key":"41654_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jnc.14006","volume":"141","author":"R Busch","year":"2017","unstructured":"Busch, R. et al. Effects of p75NTR deficiency on cholinergic innervation of the amygdala and anxiety-like behavior. J Neurochem 141, 461\u2013471, https:\/\/doi.org\/10.1111\/jnc.14006 (2017).","journal-title":"J Neurochem"},{"key":"41654_CR44","doi-asserted-by":"publisher","first-page":"E012","DOI":"10.1017\/S0952523816000080","volume":"33","author":"V Von Bohlen Und Halbach","year":"2016","unstructured":"Von Bohlen Und Halbach, V. & Von Bohlen Und Halbach, O. Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex. Vis Neurosci 33, E012, https:\/\/doi.org\/10.1017\/S0952523816000080 (2016).","journal-title":"Vis Neurosci"},{"key":"41654_CR45","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/jnr.23717","volume":"94","author":"GL Barrett","year":"2016","unstructured":"Barrett, G. L., Naim, T., Trieu, J. & Huang, M. In vivo knockdown of basal forebrain p75 neurotrophin receptor stimulates choline acetyltransferase activity in the mature hippocampus. J Neurosci Res 94, 389\u2013400, https:\/\/doi.org\/10.1002\/jnr.23717 (2016).","journal-title":"J Neurosci Res"},{"key":"41654_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/329065a0","volume":"329","author":"W Fischer","year":"1987","unstructured":"Fischer, W. et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329, 65\u201368, https:\/\/doi.org\/10.1038\/329065a0 (1987).","journal-title":"Nature"},{"key":"41654_CR47","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1523\/JNEUROSCI.11-07-01889.1991","volume":"11","author":"W Fischer","year":"1991","unstructured":"Fischer, W., Bjorklund, A., Chen, K. & Gage, F. H. NGF improves spatial memory in aged rodents as a function of age. J Neurosci 11, 1889\u20131906 (1991).","journal-title":"J Neurosci"},{"key":"41654_CR48","doi-asserted-by":"publisher","first-page":"4815","DOI":"10.1523\/JNEUROSCI.14-08-04815.1994","volume":"14","author":"AL Markowska","year":"1994","unstructured":"Markowska, A. L., Koliatsos, V. E., Breckler, S. J., Price, D. L. & Olton, D. S. Human nerve growth factor improves spatial memory in aged but not in young rats. J Neurosci 14, 4815\u20134824 (1994).","journal-title":"J Neurosci"},{"key":"41654_CR49","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1523\/JNEUROSCI.15-04-02819.1995","volume":"15","author":"KS Chen","year":"1995","unstructured":"Chen, K. S. & Gage, F. H. Somatic gene transfer of NGF to the aged brain: behavioral and morphological amelioration. J Neurosci 15, 2819\u20132825 (1995).","journal-title":"J Neurosci"},{"key":"41654_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/0306-4522(95)00099-5","volume":"68","author":"KS Chen","year":"1995","unstructured":"Chen, K. S., Masliah, E., Mallory, M. & Gage, F. H. Synaptic loss in cognitively impaired aged rats is ameliorated by chronic human nerve growth factor infusion. Neuroscience 68, 19\u201327 (1995).","journal-title":"Neuroscience"},{"key":"41654_CR51","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/0896-6273(95)90051-9","volume":"15","author":"A Martinez-Serrano","year":"1995","unstructured":"Martinez-Serrano, A., Fischer, W. & Bjorklund, A. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15, 473\u2013484 (1995).","journal-title":"Neuron"},{"key":"41654_CR52","doi-asserted-by":"publisher","first-page":"6355","DOI":"10.1073\/pnas.93.13.6355","volume":"93","author":"A Martinez-Serrano","year":"1996","unstructured":"Martinez-Serrano, A., Fischer, W., Soderstrom, S., Ebendal, T. & Bjorklund, A. Long-term functional recovery from age-induced spatial memory impairments by nerve growth factor gene transfer to the rat basal forebrain. Proc Natl Acad Sci USA 93, 6355\u20136360 (1996).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41654_CR53","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1523\/JNEUROSCI.16-17-05437.1996","volume":"16","author":"C Backman","year":"1996","unstructured":"Backman, C. et al. Systemic administration of a nerve growth factor conjugate reverses age-related cognitive dysfunction and prevents cholinergic neuron atrophy. J Neurosci 16, 5437\u20135442 (1996).","journal-title":"J Neurosci"},{"key":"41654_CR54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1006\/nbdi.1996.0008","volume":"3","author":"MN Castel-Barthe","year":"1996","unstructured":"Castel-Barthe, M. N. et al. Direct intracerebral nerve growth factor gene transfer using a recombinant adenovirus: effect on basal forebrain cholinergic neurons during aging. Neurobiol Dis 3, 76\u201386, https:\/\/doi.org\/10.1006\/nbdi.1996.0008 (1996).","journal-title":"Neurobiol Dis"},{"key":"41654_CR55","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1073\/pnas.95.4.1858","volume":"95","author":"A Martinez-Serrano","year":"1998","unstructured":"Martinez-Serrano, A. & Bjorklund, A. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc Natl Acad Sci USA 95, 1858\u20131863 (1998).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41654_CR56","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1073\/pnas.98.4.1941","volume":"98","author":"JM Conner","year":"2001","unstructured":"Conner, J. M., Darracq, M. A., Roberts, J. & Tuszynski, M. H. Nontropic actions of neurotrophins: subcortical nerve growth factor gene delivery reverses age-related degeneration of primate cortical cholinergic innervation. Proc Natl Acad Sci USA 98, 1941\u20131946, https:\/\/doi.org\/10.1073\/pnas.98.4.1941 (2001).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41654_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/cne.903490110","volume":"349","author":"DF Emerich","year":"1994","unstructured":"Emerich, D. F. et al. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol 349, 148\u2013164, https:\/\/doi.org\/10.1002\/cne.903490110 (1994).","journal-title":"J Comp Neurol"},{"key":"41654_CR58","first-page":"305","volume":"3","author":"MH Tuszynski","year":"1996","unstructured":"Tuszynski, M. H., Roberts, J., Senut, M. C., U, H. S. & Gage, F. H. Gene therapy in the adult primate brain: intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 3, 305\u2013314 (1996).","journal-title":"Gene Ther"},{"key":"41654_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.expneurol.2008.10.004","volume":"215","author":"AH Nagahara","year":"2009","unstructured":"Nagahara, A. H. et al. Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery. Exp Neurol 215, 153\u2013159, https:\/\/doi.org\/10.1016\/j.expneurol.2008.10.004 (2009).","journal-title":"Exp Neurol"},{"key":"41654_CR60","doi-asserted-by":"publisher","first-page":"10893","DOI":"10.1073\/pnas.96.19.10893","volume":"96","author":"DE Smith","year":"1999","unstructured":"Smith, D. E., Roberts, J., Gage, F. H. & Tuszynski, M. H. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy. Proc Natl Acad Sci USA 96, 10893\u201310898 (1999).","journal-title":"Proc Natl Acad Sci USA"},{"key":"41654_CR61","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/096368970000900508","volume":"9","author":"MH Tuszynski","year":"2000","unstructured":"Tuszynski, M. H. Intraparenchymal NGF infusions rescue degenerating cholinergic neurons. Cell Transplant 9, 629\u2013636 (2000).","journal-title":"Cell Transplant"},{"key":"41654_CR62","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1091\/mbc.1.2.189","volume":"1","author":"FM Longo","year":"1990","unstructured":"Longo, F. M., Vu, T. K. & Mobley, W. C. The in vitro biological effect of nerve growth factor is inhibited by synthetic peptides. Cell Regul 1, 189\u2013195 (1990).","journal-title":"Cell Regul"},{"key":"41654_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1097-4547(19970401)48:1<1::AID-JNR1>3.0.CO;2-K","volume":"48","author":"FM Longo","year":"1997","unstructured":"Longo, F. M., Manthorpe, M., Xie, Y. M. & Varon, S. Synthetic NGF peptide derivatives prevent neuronal death via a p75 receptor-dependent mechanism. J Neurosci Res 48, 1\u201317 (1997).","journal-title":"J Neurosci Res"},{"key":"41654_CR64","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.1523\/JNEUROSCI.3547-05.2006","volume":"26","author":"SM Massa","year":"2006","unstructured":"Massa, S. M. et al. Small, nonpeptide p75NTR ligands induce survival signaling and inhibit proNGF-induced death. J Neurosci 26, 5288\u20135300, https:\/\/doi.org\/10.1523\/JNEUROSCI.3547-05.2006 (2006).","journal-title":"J Neurosci"},{"key":"41654_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12031-002-0019-1","volume":"19","author":"SM Massa","year":"2002","unstructured":"Massa, S. M., Xie, Y. & Longo, F. M. Alzheimer\u2019s therapeutics: neurotrophin small molecule mimetics. J Mol Neurosci 19, 107\u2013111, https:\/\/doi.org\/10.1007\/s12031-002-0019-1 (2002).","journal-title":"J Mol Neurosci"},{"key":"41654_CR66","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrd4024","volume":"12","author":"FM Longo","year":"2013","unstructured":"Longo, F. M. & Massa, S. M. Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease. Nat Rev Drug Discov 12, 507\u2013525 (2013).","journal-title":"Nat Rev Drug Discov"},{"key":"41654_CR67","doi-asserted-by":"publisher","first-page":"e3604","DOI":"10.1371\/journal.pone.0003604","volume":"3","author":"T Yang","year":"2008","unstructured":"Yang, T. et al. Small molecule, non-peptide p75 ligands inhibit Abeta-induced neurodegeneration and synaptic impairment. PLoS One 3, e3604, https:\/\/doi.org\/10.1371\/journal.pone.0003604 (2008).","journal-title":"PLoS One"},{"key":"41654_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuro.2014.09.005","volume":"45","author":"A Friesland","year":"2014","unstructured":"Friesland, A. et al. Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR. Neurotoxicology 45, 81\u201390, https:\/\/doi.org\/10.1016\/j.neuro.2014.09.005 (2014).","journal-title":"Neurotoxicology"},{"key":"41654_CR69","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1523\/JNEUROSCI.0399-12.2013","volume":"33","author":"C Tep","year":"2013","unstructured":"Tep, C. et al. Oral administration of a small molecule targeted to block proNGF binding to p75 promotes myelin sparing and functional recovery after spinal cord injury. J Neurosci 33, 397\u2013410, https:\/\/doi.org\/10.1523\/JNEUROSCI.0399-12.2013 (2013).","journal-title":"J Neurosci"},{"key":"41654_CR70","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/j.neurobiolaging.2013.02.015","volume":"34","author":"JK Knowles","year":"2013","unstructured":"Knowles, J. K. et al. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer\u2019s mouse model. Neurobiol Aging 34, 2052\u20132063, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.02.015 (2013).","journal-title":"Neurobiol Aging"},{"key":"41654_CR71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3233\/JAD-140036","volume":"42","author":"TV Nguyen","year":"2014","unstructured":"Nguyen, T. V. et al. Small molecule p75NTR ligands reduce pathological phosphorylation and misfolding of tau, inflammatory changes, cholinergic degeneration, and cognitive deficits in AbetaPP(L\/S) transgenic mice. J Alzheimers Dis 42, 459\u2013483, https:\/\/doi.org\/10.3233\/JAD-140036 (2014).","journal-title":"J Alzheimers Dis"},{"key":"41654_CR72","doi-asserted-by":"publisher","first-page":"e102136","DOI":"10.1371\/journal.pone.0102136","volume":"9","author":"DA Simmons","year":"2014","unstructured":"Simmons, D. A. et al. A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer\u2019s disease mouse models with mid- to late-stage disease progression. PLoS One 9, e102136, https:\/\/doi.org\/10.1371\/journal.pone.0102136 (2014).","journal-title":"PLoS One"},{"key":"41654_CR73","unstructured":"Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates, 2nd Edition (Academic Press, 2001)."},{"key":"41654_CR74","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","volume":"14","author":"MJ West","year":"1993","unstructured":"West, M. J. New stereological methods for counting neurons. Neurobiol Aging 14, 275\u2013285 (1993).","journal-title":"Neurobiol Aging"},{"key":"41654_CR75","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0006-8993(90)91116-X","volume":"508","author":"MC Altavista","year":"1990","unstructured":"Altavista, M. C., Rossi, P., Bentivoglio, A. R., Crociani, P. & Albanese, A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res 508, 51\u201359 (1990).","journal-title":"Brain Res"},{"key":"41654_CR76","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnsyn.2013.00002","volume":"5","author":"LM Teles-Grilo Ruivo","year":"2013","unstructured":"Teles-Grilo Ruivo, L. M. & Mellor, J. R. Cholinergic modulation of hippocampal network function. Front Synaptic Neurosci 5, 2, https:\/\/doi.org\/10.3389\/fnsyn.2013.00002 (2013).","journal-title":"Front Synaptic Neurosci"},{"key":"41654_CR77","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0006-8993(92)90725-O","volume":"581","author":"M Svensson","year":"1992","unstructured":"Svensson, M. & Aldskogius, H. The effect of axon injury on microtubule-associated protein MAP2 mRNA in the hypoglossal nucleus of the adult rat. Brain Res 581, 319\u2013322 (1992).","journal-title":"Brain Res"},{"key":"41654_CR78","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.mad.2004.12.004","volume":"126","author":"T Himeda","year":"2005","unstructured":"Himeda, T., Mizuno, K., Kato, H. & Araki, T. Effects of age on immunohistochemical changes in the mouse hippocampus. Mech Ageing Dev 126, 673\u2013677, https:\/\/doi.org\/10.1016\/j.mad.2004.12.004 (2005).","journal-title":"Mech Ageing Dev"},{"key":"41654_CR79","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1177\/002215540104900818","volume":"49","author":"G Di Stefano","year":"2001","unstructured":"Di Stefano, G. et al. Distribution of map2 in hippocampus and cerebellum of young and old rats by quantitative immunohistochemistry. J Histochem Cytochem 49, 1065\u20131066, https:\/\/doi.org\/10.1177\/002215540104900818 (2001).","journal-title":"J Histochem Cytochem"},{"key":"41654_CR80","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000147507","volume":"147","author":"JM Kerwin","year":"1993","unstructured":"Kerwin, J. M., Morris, C. M., Johnson, M., Perry, R. H. & Perry, E. K. Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence. Acta Anat (Basel) 147, 216\u2013222 (1993).","journal-title":"Acta Anat (Basel)"},{"key":"41654_CR81","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/exnr.1997.6504","volume":"146","author":"EJ Mufson","year":"1997","unstructured":"Mufson, E. J. et al. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer\u2019s disease. Exp Neurol 146, 91\u2013103, https:\/\/doi.org\/10.1006\/exnr.1997.6504 (1997).","journal-title":"Exp Neurol"},{"key":"41654_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1385\/JMN:25:2:141","volume":"25","author":"C Costantini","year":"2005","unstructured":"Costantini, C. et al. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. J Mol Neurosci 25, 141\u2013156, https:\/\/doi.org\/10.1385\/JMN:25:2:141 (2005).","journal-title":"J Mol Neurosci"},{"key":"41654_CR83","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/sj.emboj.7601062","volume":"25","author":"C Costantini","year":"2006","unstructured":"Costantini, C., Scrable, H. & Puglielli, L. An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J 25, 1997\u20132006, https:\/\/doi.org\/10.1038\/sj.emboj.7601062 (2006).","journal-title":"EMBO J"},{"key":"41654_CR84","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.neulet.2006.11.040","volume":"413","author":"B Williams","year":"2007","unstructured":"Williams, B., Granholm, A. C. & Sambamurti, K. Age-dependent loss of NGF signaling in the rat basal forebrain is due to disrupted MAPK activation. Neurosci Lett 413, 110\u2013114, https:\/\/doi.org\/10.1016\/j.neulet.2006.11.040 (2007).","journal-title":"Neurosci Lett"},{"key":"41654_CR85","doi-asserted-by":"publisher","first-page":"9989","DOI":"10.1523\/JNEUROSCI.2492-05.2005","volume":"25","author":"M Zagrebelsky","year":"2005","unstructured":"Zagrebelsky, M. et al. The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci 25, 9989\u20139999, https:\/\/doi.org\/10.1523\/JNEUROSCI.2492-05.2005 (2005).","journal-title":"J Neurosci"},{"key":"41654_CR86","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1172\/JCI97837","volume":"128","author":"JC Ryu","year":"2018","unstructured":"Ryu, J. C. et al. Role of proNGF\/p75 signaling in bladder dysfunction after spinal cord injury. J Clin Invest 128, 1772\u20131786, https:\/\/doi.org\/10.1172\/JCI97837 (2018).","journal-title":"J Clin Invest"},{"key":"41654_CR87","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nn1510","volume":"8","author":"NH Woo","year":"2005","unstructured":"Woo, N. H. et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 8, 1069\u20131077, https:\/\/doi.org\/10.1038\/nn1510 (2005).","journal-title":"Nat Neurosci"},{"key":"41654_CR88","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/bpa.12199","volume":"25","author":"HJ Nell","year":"2015","unstructured":"Nell, H. J., Whitehead, S. N. & Cechetto, D. F. Age-Dependent Effect of beta-Amyloid Toxicity on Basal Forebrain Cholinergic Neurons and Inflammation in the Rat Brain. Brain Pathol 25, 531\u2013542, https:\/\/doi.org\/10.1111\/bpa.12199 (2015).","journal-title":"Brain Pathol"},{"key":"41654_CR89","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nm0798-827","volume":"4","author":"C Geula","year":"1998","unstructured":"Geula, C. et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4, 827\u2013831 (1998).","journal-title":"Nat Med"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41654-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41654-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41654-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:15:37Z","timestamp":1671264937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-41654-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["41654"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-41654-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"28 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Drs Longo and Massa are listed as inventors on patents relating to a compound in this report that is assigned to the University of North Carolina, University of California, San Francisco and the Dept. of Veterans Affairs. Drs Massa and Longo are entitled to royalties distributed by UC and the VA per their standard agreements. Dr. Longo is a principal of, and has financial interest in PharmatrophiX, a company focused on the development of small molecule ligands for neurotrophin receptors that has licensed several of these patents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5273"}}